Atlas Trials

BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple Myeloma

Clinical trial NCT03093168 · UNKNOWN

Trial details

NCT number
NCT03093168
Sponsor
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2017-02-15
Primary completion
2019-09-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.